Metabotropic glutamate receptor 5 antagonist-induced stimulation of hypothalamic-pituitary-adrenal axis activity: Interaction with serotonergic systems

Neuropharmacology

Volumn 44, Issue 5, 2003, Pages 562-572

  Bradbury, M J ^a   Giracello, D R ^a   Chapman, D F ^a   Holtz, G ^a   Schaffhauser, H ^a   Rao, S P ^a   Varney, M A ^a   Anderson, J J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

5 HT1A receptor; Antidepressant; Anxiolytic; mGluR5

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; BUSPIRONE; CORTICOSTERONE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); METABOTROPIC RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PROTEIN SUBUNIT; SEROTONIN; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DESENSITIZATION; DOSE RESPONSE; DRUG EFFECT; FOLLOW UP; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SEROTONINERGIC SYSTEM;

EID: 0037380838     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00048-0     Document Type: Article

References (41)

1. Anderson J.J., Rao S.P., Rowe B., Giracello D.R., Holtz G., Chapman D.F., Tehrani L., Bradbury M.J., Cosford N.D., Varney M.A. [3H]methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization. J Pharmacol Exp Ther. 303:2002;1044-1051.
2. Blier P. Pharmacology of rapid-onset antidepressant treatment strategies. J Clin Psychiatry. 62:2001;12-17.
3. Brodkin J., Busse C., Sukoff S.J., Varney M.A. Anxiolytic-like activity of the mGluR5 antagonist MPEP. A comparison with diazepam and buspirone. Pharmacol Biochem Behav. 73:2002;359-366.
4. Cole R.L., Sawchenko P.E. Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. J Neurosci. 22:2002;959-969.
5. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol. 37:1997;205-237.
6. Cosford N.D., Roppe J., Tehrani L., Schweiger E.J., Seiders T.J., Chaudary A., Rao S., Varney M.A. [3H]-Methoxyme-thyl-MTEP and [3H]-Methoxy-PEPy: Potent and selective radio ligands for the metabotropic subtype 5 (mGlu5) receptor. Bioorg Med Chem Lett. 13:2003;351-354.
7. Cowan P.J. Neuroendocrine challenge tests: What can we learn from them? Methods in Neuroendocrinology. 1998;205-223 CRC Press, Boca Raton.
8. De Boer S.F., Slangen J.L., Van der Gugten J. Effects of buspirone and chlordiazepoxide on plasma catecholamine and corticosterone levels in stressed and nonstressed rats. Pharmacol Biochem Behav. 38:1991;299-308.
9. Duncan G.E., Knapp D.J., Carson S.W., Breese G.R. Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. J Pharmacol Exp Ther. 285:1998;579-587.
10. Fuller R.W. Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats. Behav Brain Res. 73:1996;215-219.
11. Gasparini F., Lingenhohl K., Stoehr N., Flor P.J., Heinrich M., Vranesic I., Biollaz M., Allgeier H., Heckendorn R., Urwyler S., Varney M.A., Johnson E.C., Hess S.D., Rao S.P., Sacaan A.I., Santori E.M., Velicelebi G., Kuhn R. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology. 38:1999;1493-1503.
12. Gur E., Dremencov E., Van De Kar L.D., Lerer B., Newman M.E. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus. Eur J Pharmacol. 436:2002;57-65.
13. Hensler J.G. Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology. 26:2002;565-573.
14. Hervas I., Vilaro M.T., Romero L., Scorza M.C., Mengod G., Artigas F. Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology. 24:2001;11-20.
15. Johnson M.P., Kelly G., Chamberlain M. Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists. J Neuroendocrinol. 13:2001;670-677.
16. Jorgensen H., Knigge U., Kjaer A., Vadsholt T., Warberg J. Serotonergic involvement in stress-induced ACTH release. Brain Res. 811:1998;10-20.
17. Kageyama K., Tozawa F., Horiba N., Watanobe H., Suda T. Serotonin stimulates corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Neurosci Lett. 243:1998;17-20.
18. Kantor S., Graf M., Anheuer Z.E., Bagdy G. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment. Eur Neuropsychopharmacol. 11:2001;15-24.
19. Lerer B., Gelfin Y., Gorfine M., Allolio B., Lesch K.P., Newman M.E. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology. 20:1999;628-639.
20. Lesch K.P., Hoh A., Schulte H.M., Osterheider M., Muller T. Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology. 105:1991;415-420.
21. Li Q., Muma N.A., Battaglia G., Van de Kar L.D. A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. J Pharmacol Exp Ther. 282:1997;1581-1590.
22. Marek G.J., Wright R.A., Schoepp D.D., Monn J.A., Aghajanian G.K. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther. 292:2000;76-87.
23. Martin-Ruiz R., Puig M.V., Celada P., Shapiro D.A., Roth B.L., Mengod G., Artigas F. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci. 21:2001;9856-9866.
24. Matheson G.K., Raess B.U., Tunnicliff G. Effects of repeated doses of azapirones on rat brain 5-HT1A receptors and plasma corticosterone levels. Gen Pharmacol. 27:1996;355-361.
25. Raap D.K., Evans S., Garcia F., Li Q., Muma N.A., Wolf W.A., Battaglia G., Van De Kar L.D. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. J Pharmacol Exp Ther. 288:1999;98-106.
26. Ransom R.W., Stec N.L. Cooperative modulation of [3H]MK-801 binding to the N-methyl-D- aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J Neurochem. 51:1988;830-836.
27. Reul J.M., Labeur M.S., Grigoriadis D.E., De Souza E.B., Holsboer F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology. 60:1994;509-519.
28. Roland B.L., Sawchenko P.E. Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp Neurol. 332:1993;123-143.
29. Serres F., Li Q., Garcia F., Raap D.K., Battaglia G., Muma N.A., Van de Kar L.D. Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo. J Neurosci. 20:2000;3095-3103.
30. Serres F., Muma N.A., Raap D.K., Garcia F., Battaglia G., Van de Kar L.D. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus. J Pharmacol Exp Ther. 294:2000;296-301.
31. Shen C., Li H., Meller E. Repeated treatment with antidepressants differentially alters 5-HT1A agonist-stimulated [35S]GTP gamma S binding in rat brain regions. Neuropharmacology. 42:2002;1031-1038.
32. Spooren W.P., Gasparini F., Salt T.E., Kuhn R. Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders. Trends Pharmacol Sci. 22:2001;331-337.
33. Spooren W.P., Vassout A., Neijt H.C., Kuhn R., Gasparini F., Roux S., Porsolt R.D., Gentsch C. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther. 295:2000;1267-1275.
34. Tasker J.G., Boudaba C., Schrader L.A. Local glutamatergic and GABAergic synaptic circuits and metabotropic glutamate receptors in the hypothalamic paraventricular and supraoptic nuclei. Adv Exp Med Biol. 449:1998;117-121.
35. Tatarczynska E., Klodzinska A., Chojnacka-Wojcik E., Palucha A., Gasparini F., Kuhn R., Pilc A. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol. 132:2001;1423-1430.
36. Van de Kar L.D., Blair M.L. Forebrain pathways mediating stress-induced hormone secretion. Front Neuroendocrinol. 20:1999;1-48.
37. van den Pol A.N., Romano C., Ghosh P. Metabotropic glutamate receptor mGluR5 subcellular distribution and developmental expression in hypothalamus. J Comp Neurol. 362:1995;134-150.
38. Wieronska J.M., Branski P., Szewczyk B., Palucha A., Papp M., Gruca P., Moryl E., Pilc A. Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in the rat hippocampus in an animal model of depression. Pol J Pharmacol. 53:2001;659-662.
39. Zhang Y., D'Souza D., Raap D.K., Garcia F., Battaglia G., Muma N.A., Van de Kar L.D. Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation. J Neurosci. 21:2001;7919-7927.
40. Zhang Y., Raap D.K., Garcia F., Serres F., Ma Q., Battaglia G., Van de Kar L.D. Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats. Brain Res. 855:2000;58-66.
41. Ziegler D.R., Herman J.P. Local integration of glutamate signaling in the hypothalamic paraventricular region: regulation of glucocorticoid stress responses. Endocrinology. 141:2000;4801-4804.